Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Innate Pharma S.A. ADR (NQ: IPHA )

2.150 +0.010 (+0.47%)
Streaming Delayed Price Updated: 2:03 PM EDT, Sep 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Innate Pharma S.A. ADR

< Previous 1 2 3 4 5 6 7 8 Next >
Mid-Day Market Update: Crude Oil Jumps Over 2%; Assembly Biosciences Shares Plunge
Midway through trading Thursday, the Dow traded up 0.42% to 35,461.47 while the NASDAQ rose 0.39% to 15,369.38. The S&P also rose, gaining 0.38% to 4,541.06. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
46 Stocks Moving In Thursday's Mid-Day Session
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 36% to $9.02 as traders circulate a tweet from popular Twitter trader Will Meade saying 'Long $ANY this is the next $SPRT... 
Via Benzinga
Mid-Morning Market Update: Markets Open Higher; Hormel Foods Cuts Earnings Outlook
Following the market opening Thursday, the Dow traded up 0.18% to 35,377.03 while the NASDAQ rose 0.23% to 15,345.05. The S&P also rose, gaining 0.27% to 4,536.45. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Earnings Scheduled For May 11, 2021
Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Plus Therapeutics (NASDAQ:PSTV) shares increased by 22.1% to $2.32 during Thursday's pre-market session. The company's market cap stands at $28.0 million.... 
Via Benzinga
28 Stocks Moving in Thursday's Pre-Market Session
Gainers Focus Universal Inc. (NASDAQ: FCUV) rose 39.7% to $26.93 in pre-market trading after jumping 278% on Wednesday. Focus Universal recently priced 2 million shares at $5 per... 
Via Benzinga
Innate Pharma To Stop COVID-19 Trial With Avdoralimab After Mid-Stage Study Disappoints
Innate Pharma SA (NASDAQ: IPHA) has announced its Phase 2 FORCE trial evaluating avdoralimab in COVID-19 patients with severe pneumonia did not meet its primary... 
Via Benzinga
Exposures COVID-19
Stocks That Hit 52-Week Lows On Wednesday
During Wednesday's morning session, 29 stocks hit new 52-week lows. Points of Interest: The largest company by market cap to set a new 52-week low was CoStar Gr (... 
Via Benzinga
The Daily Biotech Pulse: Pfizer's Positive Readout, NRx Strikes R&D Collaboration With Mannkind, Cerus & Invitae Jump On Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 3) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated... 
Via Benzinga
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen's Anemia Drug, Corvus Shelves COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 15) IVERIC bio, Inc. (NASDAQ:... 
Via Benzinga
Topics Stocks
Exposures US Equities
The Daily Biotech Pulse: Spero Spikes On Pfizer Investment, FDA Nod For Jazz, Orchard Signs Licensing Deal, Acumen Pharma Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 30) Ambrx Biopharma Inc. (NYSE... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Ocuphire Pharma (NASDAQ:OCUP) shares increased by 63.57% to $7.77 during Wednesday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
Innate Pharma's Lacutamab Shows Clinical Responses In KIR3DL2-Expressing Mycosis Fungoides Patients
Innate Pharma SA (NASDAQ: IPHA) has announced preliminary data from the mycosis fungoides (MF) cohort of the Phase 2 TELLOMAK clinical trial, evaluating lacutamab... 
Via Benzinga
The Daily Biotech Pulse: Gemini Sinks On Data, Amgen's Migraine Drug Approved In Japan, Liver Congress Gets Underway
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 22) AngioDynamics, Inc. (NASDAQ... 
Via Benzinga
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries. 
Via Talk Markets
Exposures Product Safety
The Daily Biotech Pulse: Sanofi, Translate Bio Start Early Stage Seasonal Flu Vaccine Study, Dr. Reddy's Launches Generic Vascepa, Halozyme Strikes Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 21) Agios Pharmaceuticals, Inc... 
Via Benzinga
The Week Ahead In Biotech: Incyte, Ascendis FDA Decisions, Liver Congress Presentations And 4 IPOs
Biotech stocks came under pressure in the week ended June 18, dragged by the negative sentiment that prevailed in the broader market due to macroeconomic worries. The U.S. Federal... 
Via Benzinga
Exposures Product Safety
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Paratek Pharmaceuticals (NASDAQ:PRTK) stock increased by 12.65% to $9.26 during Tuesday's pre-market session. The company's market cap stands at $434.5... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.